Published in J Pharmacol Exp Ther on May 01, 1971
On the mechanism of L-dopa-induced postural hypotension in the cat. Br J Pharmacol (1973) 0.98
An analysis of the peripheral effects of l-DOPA on autonomic nerve function. Br J Pharmacol (1974) 0.75
Outcomes after long-term acute care. An analysis of 133 mechanically ventilated patients. Am J Respir Crit Care Med (1999) 2.84
Antiopsonic activity of fibrinogen bound to M protein on the surface of group A streptococci. J Clin Invest (1982) 2.19
Hyaluronate capsule prevents attachment of group A streptococci to mouse peritoneal macrophages. Infect Immun (1981) 2.03
The potential of health sector non-governmental organizations: policy options. Health Policy Plan (1994) 1.98
Causes and outcome of young infant admissions to a Kenyan district hospital. Arch Dis Child (2003) 1.81
Biochemical and biological properties of the binding of human fibrinogen to M protein in group A streptococci. J Bacteriol (1985) 1.77
A clinical and genetic study of the Say/Barber/Biesecker/Young-Simpson type of Ohdo syndrome. Clin Genet (2008) 1.71
Hydrophobic interactions of group A streptococci with hexadecane droplets. J Bacteriol (1983) 1.67
Inhibition of complement-mediated opsonization and phagocytosis of Streptococcus pyogenes by D fragments of fibrinogen and fibrin bound to cell surface M protein. J Exp Med (1985) 1.65
Common protective antigens of group A streptococcal M proteins masked by fibrinogen. J Exp Med (1984) 1.59
The predictable relationship between plasma levels and dose during chronic propranolol therapy. Clin Pharmacol Ther (1978) 1.51
THE EFFECTS OF AUTONOMIC NERVOUS SYSTEM INHIBITION ON THE CIRCULATORY RESPONSE TO MUSCULAR EXERCISE. J Clin Invest (1962) 1.41
Abnormal expression of wild type p53 protein in normal cells of a cancer family patient. Lancet (1992) 1.41
Cowden syndrome and Lhermitte-Duclos disease in a family: a single genetic syndrome with pleiotropy? J Med Genet (1994) 1.33
The effects of injected norepinephrine and sympathetic nerve stimulation in hypothyroid and hyperthyroid dogs. J Pharmacol Exp Ther (1965) 1.29
In vivo measurements of macular and nerve fibre layer thickness in retinal arterial occlusion. Eye (Lond) (2006) 1.28
Postprandial alterations in hemodynamics and blood pressure in normal subjects. Am J Cardiol (1986) 1.25
Diffusing capacity predicts morbidity and mortality after pulmonary resection. J Thorac Cardiovasc Surg (1988) 1.23
Bacillus cereus pneumonia. Survival in a patient with cavitary disease treated with gentamicin. Am Rev Respir Dis (1977) 1.22
Identification of higher brain centres that may encode the cardiorespiratory response to exercise in humans. J Physiol (2001) 1.21
Attitudes towards blood donation in Trinidad and Tobago. Transfus Med (2007) 1.20
Abnormal blood glucose concentrations on admission to a rural Kenyan district hospital: prevalence and outcome. Arch Dis Child (2003) 1.18
Propranolol metabolism in man and dog: mass spectrometric identification of six new metabolites. J Pharmacol Exp Ther (1972) 1.17
A possible screening test for inherited p53-related defects based on the apoptotic response of peripheral blood lymphocytes to DNA damage. Br J Cancer (1995) 1.17
Paraneoplastic "stiff person syndrome" with metastatic adenocarcinoma and anti-Ri antibodies. Neurology (2004) 1.15
Noun imageability and the temporal lobes. Neuropsychologia (2000) 1.14
MLL2 mutation detection in 86 patients with Kabuki syndrome: a genotype-phenotype study. Clin Genet (2013) 1.13
Functional domains of the HIV-1 rev gene required for trans-regulation and subcellular localization. Virology (1990) 1.13
Naphthoxylactic acid after single and long-term doses of propranolol. Clin Pharmacol Ther (1979) 1.10
The Viking viewer for connectomics: scalable multi-user annotation and summarization of large volume data sets. J Microsc (2011) 1.07
Immortalization in culture: occurrence at a late stage in the progression of breast cancer. J Natl Cancer Inst (1987) 1.07
Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis. Neuromuscul Disord (2013) 1.05
Mutations and alternative splicing of the BRCA1 gene in UK breast/ovarian cancer families. Genes Chromosomes Cancer (1997) 1.03
Interfamilial phenotypic heterogeneity in SMARD1. Neuromuscul Disord (2009) 1.03
Sacroiliitis associated with pyelonephritis in pregnancy. Obstet Gynecol (1995) 1.03
The pathogenesis of pulmonary and miliary tuberculosis. Arch Intern Med (1979) 1.01
4-Hydroxypropranolol and its glucuronide after single and long-term doses of propranolol. Clin Pharmacol Ther (1980) 1.00
p53 inhibits mRNA 3' processing through its interaction with the CstF/BARD1 complex. Oncogene (2011) 0.98
A randomised, controlled trial of once daily and multi-dose daily gentamicin in young Kenyan infants. Arch Dis Child (2004) 0.98
Thomas Laycock and the cerebral reflex: a function arising from and pointing to the unity of nature. Hist Psychiatry (1991) 0.98
Food-induced increase in propranolol bioavailability--relationship to protein and effects on metabolites. Clin Pharmacol Ther (1981) 0.98
Pleural effusion from malignancy. Ann Intern Med (1978) 0.98
Use of polymerase chain reaction to demonstrate cytomegalovirus DNA in CSF of patients with human immunodeficiency virus infection. Neurology (1993) 0.97
Hutchinson-Gilford progeria syndrome: clinical findings in three patients carrying the G608G mutation in LMNA and review of the literature. Br J Dermatol (2007) 0.97
Outcomes and resource utilization for patients with prolonged critical illness managed by university-based or community-based subspecialists. Am J Respir Crit Care Med (1998) 0.97
Assessment of right ventricular systolic function using tricuspid annular-plane systolic excursion in Nigerians with systemic hypertension. Cardiovasc J Afr (2010) 0.96
Fibrinogen binding and resistance to phagocytosis of Streptococcus sanguis expressing cloned M protein of Streptococcus pyogenes. Infect Immun (1989) 0.94
Effect of methyldopa on plasma renin activity in man. Circ Res (1969) 0.93
Depression among adolescents, aged 13-19 years, attending secondary schools in Trinidad: prevalence and associated factors. West Indian Med J (2008) 0.93
Exercise-induced increments in plasma levels of propranolol and noradrenaline. Br J Clin Pharmacol (1983) 0.92
Reversal of sympathetic nerve blockade: a comparison of dopa, dopamine, and norepinephrine with their alpha-methylated analogues. J Pharmacol Exp Ther (1965) 0.92
Current practices and medico-legal aspects of pre-operative consent. East Afr Med J (2004) 0.92
Stereoselective clearance and distribution of intravenous propranolol. Clin Pharmacol Ther (1984) 0.90
Identification of missense and truncating mutations in the BRCA1 gene in sporadic and familial breast and ovarian cancer. Genes Chromosomes Cancer (1998) 0.90
Phosphopeptide quantitation using amine-reactive isobaric tagging reagents and tandem mass spectrometry: application to proteins isolated by gel electrophoresis. Rapid Commun Mass Spectrom (2006) 0.89
Male and female salivary testosterone concentrations before and after sexual activity. Physiol Behav (1992) 0.87
Global guidelines for treatment of tuberculosis among persons living with HIV: unresolved issues. Int J Tuberc Lung Dis (2012) 0.86
Tuberculosis chemoprophylaxis practices in metropolitan clinics. Am Rev Respir Dis (1979) 0.86
A precursor of the nitric oxide donor SIN-1 modulates the stress protein heme oxygenase-1 in rat liver. Biochem Biophys Res Commun (1996) 0.86
Presystemic and systemic glucuronidation of propranolol. Clin Pharmacol Ther (1979) 0.86
Isopropylamine, a biologically active deamination product of propranolol in dogs: identification of deuterated and unlabeled isopropylamine by gas chromatography-mass spectrometry. J Pharmacol Exp Ther (1972) 0.85
Human plasma fibronectin inhibits adherence of Streptococcus pyogenes to hexadecane. Infect Immun (1985) 0.85
p53 protein detected by immunohistochemical staining is not always mutant. Dis Markers (1993) 0.85
Stimulation-induced release of propranolol and norepinephrine from adrenergic neurons. J Pharmacol Exp Ther (1979) 0.84
Public health and preventive aspects of pulmonary tuberculosis. Infectiousness, epidemiology, risk factors, classification, and preventive therapy. Arch Intern Med (1979) 0.84
Adrenergic blocking and cardiovascular effects of a new N-substituted tetrahydroisoquinoline (NC 7197). J Pharmacol Exp Ther (1971) 0.84
Attachment of Streptococcus pyogenes to mammalian cells. Rev Infect Dis (1983) 0.84
Sickle cell disease in permanent residents of mountain and low altitudes in Saudi Arabia. Trop Geogr Med (1990) 0.84
Low prevalence of germline BRCA1 mutations in early onset breast cancer without a family history. J Med Genet (2000) 0.84
Bone changes in sickle cell anaemia. East Afr Med J (1993) 0.84
Adrenergic nerve stimulation-induced release of propranolol from the perfused hindlimb and spleen of the dog and associated changes in postjunctional response. J Pharmacol Exp Ther (1983) 0.83
Pathophysiology and management of the complications resulting from fire and the inhaled products of combustion: review of the literature. Crit Care Med (1980) 0.83
Knowledge, attitudes and practices of anabolic steroid usage among gym users in Trinidad. West Indian Med J (2000) 0.83
Survival of patients with sickle cell anemia living at high altitude. South Med J (1990) 0.82
Demethylation of nortriptyline by the dog lung. J Pharmacol Exp Ther (1972) 0.82
Streptococcal defenses against host immune attack: the M protein-fibrinogen interaction. Trans Assoc Am Physicians (1983) 0.82
Characteristics and outcome of cardiopulmonary resuscitation in hospitalised African children. Resuscitation (2008) 0.82
Stereoselective ring oxidation of propranolol in man. Br J Clin Pharmacol (1984) 0.82
A lethal presentation of de novo deletion 7q. J Med Genet (1987) 0.81
Depolarization-induced release of propranolol and atenolol from rat cortical synaptosomes. Br J Pharmacol (1985) 0.81
Genetic predictors of cardiovascular morbidity in Bardet-Biedl syndrome. Clin Genet (2014) 0.81
O-methylated catechol-like metabolites of propranolol in man. Drug Metab Dispos (1978) 0.80
Pathogenesis of asthma. Neurophysiology and pharmacology of bronchospasm. Chest (1982) 0.80
Identification of 5-meta-hydroxyphenyl-5-phenylhydantoin as a metabolite of diphenylhydantoin. Biochem Pharmacol (1970) 0.80
The clinical pharmacology of antihypertensive drugs. Prog Cardiovasc Dis (1969) 0.80
Ultrastructural localization of the fibrinogen-binding domain of streptococcal M protein. Infect Immun (1989) 0.80
A stereoselective central hypotensive action of atenolol. J Pharmacol Exp Ther (1989) 0.80
Selective induction of propranolol metabolism by smoking: additional effects on renal clearance of metabolites. J Pharmacol Exp Ther (1987) 0.79
Increased clearance of propranolol and theophylline by high-protein compared with high-carbohydrate diet. Clin Pharmacol Ther (1987) 0.79
Sex differences in the features of coronary artery disease of patients undergoing coronary angiography. Can J Cardiol (1996) 0.79
Canine bronchoconstriction, gas trapping, and hypoxia with methacholine. J Appl Physiol (1985) (1987) 0.79
Effect of methyldopa, reserpine and guanethidine on hindleg vascular resistance. J Pharmacol Exp Ther (1968) 0.78
Exclusion of uniparental inheritance of chromosome 15 in a fetus with a familial dicentric (Y;15) translocation. Prenat Diagn (1998) 0.78
Tuberculosis. A chemotherapeutic triumph but a persistent socioeconomic problem. Arch Intern Med (1979) 0.78
Laboratory identification of factor VIII inhibitors in the real world: the experience from Australasia. Haemophilia (2010) 0.78
Clinical audit of antiphospholipid antibody testing in tertiary practice: towards improved relevance in thrombophilia investigations. Intern Med J (2010) 0.78